CYP2C9*3 gene variant contributes...

Journal of Clinical Pharmacy and Therapeutics 2018 / 05

CYP2C9*3 gene variant contributes independently to glycaemic control in patients with type 2 diabetes treated with glibenclamide

Castelán-Martínez, O. D., Hoyo-Vadillo, C., Bazán-Soto, T. B., Cruz, M., Tesoro-Cruz, E., Valladares-Salgado, A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Journal of Clinical Pharmacy and Therapeutics
DOI:
10.1111/jcpt.12710
Date:
May, 2018
File:
PDF, 638 KB
english, 2018
Conversion to is in progress
Conversion to is failed